Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.05% advanced 3.87% to $125.67 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.84% rising 3.34% to 11,176.41 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.11% rising 2.80% to 30,316.32. This was the stock's third consecutive day of gains. Moderna Inc. closed $250.98 below its 52-week high ($376.65), which the company achieved on November 29th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.52% rose 2.65% to $141.99, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.03% rose 1.12% to $233.02, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.35% rose 2.68% to $57.04. Trading volume (3.5 M) remained 1.4 million below its 50-day average volume of 4.8 M.